Starboard Issues Investor Presentation Opposing Bristol-Myers Squibb's (BMY) Ill-Advised Proposed Acquisition of Celgene (CELG)

March 19, 2019 7:04 AM
Starboard Value LP (together with its affiliates, "Starboard"), a stockholder of Bristol-Myers Squibb Company ("Bristol-Myers" or the "Company")(NYSE: BMY) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Hedge Funds Mergers and Acquisitions

Next Articles